COVID-19 Impact on Eye Drug Market, Global Research Reports 2020-2021

COVID-19 Impact on Eye Drug Market, Global Research Reports 2020-2021

May 2020 QYResearch Pharmaceutical101 Pages Price :
$ 3250
This report covers market size and forecasts of Eye Drug, including the following market information:
Global Eye Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Eye Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Eye Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Eye Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

Key market players
Major competitors identified in this market include Pfizer, Novartis, bausch Lomb, Laboratoire Riva, Jamp Pharma, Fresenius, Teva Pharmaceutical?, SANDOZ, Greenstone, Mylan, GE Medical, Mint Pharmaceuticals, Laboratoires Thea, Taj Pharmaceuticals, Actavis, APOTEX, Sun Pharma, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Drops
Tablet & Capsule

Based on the Application:
Glaucoma
Retinal Disease
Bacterial?Infection
Other
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Eye Drug Industry
1.7 COVID-19 Impact: Eye Drug Market Trends

2 Global Eye Drug Quarterly Market Size Analysis
2.1 Eye Drug Business Impact Assessment - COVID-19
2.1.1 Global Eye Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Eye Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Eye Drug Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 Global Eye Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Eye Drug Factory Price by Manufacturers
3.3 Location of Key Manufacturers Eye Drug Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Eye Drug Market
3.5 Key Manufacturers Eye Drug Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Eye Drug Segments, By Type
4.1 Introduction
1.4.1 Drops
1.4.2 Tablet & Capsule
4.2 By Type, Global Eye Drug Market Size, 2019-2021
4.2.1 By Type, Global Eye Drug Market Size by Type, 2020-2021
4.2.2 By Type, Global Eye Drug Price, 2020-2021

5 Impact of Covid-19 on Eye Drug Segments, By Application
5.1 Overview
5.5.1 Glaucoma
5.5.2 Retinal Disease
5.5.3 Bacterial?Infection
5.5.4 Other
5.2 By Application, Global Eye Drug Market Size, 2019-2021
5.2.1 By Application, Global Eye Drug Market Size by Application, 2019-2021
5.2.2 By Application, Global Eye Drug Price, 2020-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Eye Drug Quarterly Production and Revenue, 2020
7.1.3 Pfizer Eye Drug Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Eye Drug Quarterly Production and Revenue, 2020
7.2.3 Novartis Eye Drug Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 bausch Lomb
7.3.1 bausch Lomb Business Overview
7.3.2 bausch Lomb Eye Drug Quarterly Production and Revenue, 2020
7.3.3 bausch Lomb Eye Drug Product Introduction
7.3.4 bausch Lomb Response to COVID-19 and Related Developments
7.4 Laboratoire Riva
7.4.1 Laboratoire Riva Business Overview
7.4.2 Laboratoire Riva Eye Drug Quarterly Production and Revenue, 2020
7.4.3 Laboratoire Riva Eye Drug Product Introduction
7.4.4 Laboratoire Riva Response to COVID-19 and Related Developments
7.5 Jamp Pharma
7.5.1 Jamp Pharma Business Overview
7.5.2 Jamp Pharma Eye Drug Quarterly Production and Revenue, 2020
7.5.3 Jamp Pharma Eye Drug Product Introduction
7.5.4 Jamp Pharma Response to COVID-19 and Related Developments
7.6 Fresenius
7.6.1 Fresenius Business Overview
7.6.2 Fresenius Eye Drug Quarterly Production and Revenue, 2020
7.6.3 Fresenius Eye Drug Product Introduction
7.6.4 Fresenius Response to COVID-19 and Related Developments
7.7 Teva Pharmaceutical?
7.7.1 Teva Pharmaceutical? Business Overview
7.7.2 Teva Pharmaceutical? Eye Drug Quarterly Production and Revenue, 2020
7.7.3 Teva Pharmaceutical? Eye Drug Product Introduction
7.7.4 Teva Pharmaceutical? Response to COVID-19 and Related Developments
7.8 SANDOZ
7.8.1 SANDOZ Business Overview
7.8.2 SANDOZ Eye Drug Quarterly Production and Revenue, 2020
7.8.3 SANDOZ Eye Drug Product Introduction
7.8.4 SANDOZ Response to COVID-19 and Related Developments
7.9 Greenstone
7.9.1 Greenstone Business Overview
7.9.2 Greenstone Eye Drug Quarterly Production and Revenue, 2020
7.9.3 Greenstone Eye Drug Product Introduction
7.9.4 Greenstone Response to COVID-19 and Related Developments
7.10 Mylan
7.10.1 Mylan Business Overview
7.10.2 Mylan Eye Drug Quarterly Production and Revenue, 2020
7.10.3 Mylan Eye Drug Product Introduction
7.10.4 Mylan Response to COVID-19 and Related Developments
7.11 GE Medical
7.11.1 GE Medical Business Overview
7.11.2 GE Medical Eye Drug Quarterly Production and Revenue, 2020
7.11.3 GE Medical Eye Drug Product Introduction
7.11.4 GE Medical Response to COVID-19 and Related Developments
7.12 Mint Pharmaceuticals
7.12.1 Mint Pharmaceuticals Business Overview
7.12.2 Mint Pharmaceuticals Eye Drug Quarterly Production and Revenue, 2020
7.12.3 Mint Pharmaceuticals Eye Drug Product Introduction
7.12.4 Mint Pharmaceuticals Response to COVID-19 and Related Developments
7.13 Laboratoires Thea
7.13.1 Laboratoires Thea Business Overview
7.13.2 Laboratoires Thea Eye Drug Quarterly Production and Revenue, 2020
7.13.3 Laboratoires Thea Eye Drug Product Introduction
7.13.4 Laboratoires Thea Response to COVID-19 and Related Developments
7.14 Taj Pharmaceuticals
7.14.1 Taj Pharmaceuticals Business Overview
7.14.2 Taj Pharmaceuticals Eye Drug Quarterly Production and Revenue, 2020
7.14.3 Taj Pharmaceuticals Eye Drug Product Introduction
7.14.4 Taj Pharmaceuticals Response to COVID-19 and Related Developments
7.15 Actavis
7.15.1 Actavis Business Overview
7.15.2 Actavis Eye Drug Quarterly Production and Revenue, 2020
7.15.3 Actavis Eye Drug Product Introduction
7.15.4 Actavis Response to COVID-19 and Related Developments
7.16 APOTEX
7.16.1 APOTEX Business Overview
7.16.2 APOTEX Eye Drug Quarterly Production and Revenue, 2020
7.16.3 APOTEX Eye Drug Product Introduction
7.16.4 APOTEX Response to COVID-19 and Related Developments
7.17 Sun Pharma
7.17.1 Sun Pharma Business Overview
7.17.2 Sun Pharma Eye Drug Quarterly Production and Revenue, 2020
7.17.3 Sun Pharma Eye Drug Product Introduction
7.17.4 Sun Pharma Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis
8.1 Eye Drug Supply Chain Analysis
8.1.1 Eye Drug Supply Chain Analysis
8.1.2 Covid-19 Impact on Eye Drug Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Eye Drug Distribution Channels
8.2.2 Covid-19 Impact on Eye Drug Distribution Channels
8.2.3 Eye Drug Distributors
8.3 Eye Drug Customers

9 Key Findings

10 Appendix
10.1 About Us
10.2 Disclaimer

List of Table

List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Eye Drug Assessment
Table 9. COVID-19 Impact: Eye Drug Market Trends
Table 10. COVID-19 Impact Global Eye Drug Market Size
Table 11. Global Eye Drug Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)
Table 12. Global Eye Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Kg)
Table 13. Global Eye Drug Quarterly Market Size, 2020 (US$ Million) & (MT)
Table 14. Global Eye Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Eye Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)
Table 16. Global Eye Drug Market Growth Drivers
Table 17. Global Eye Drug Market Restraints
Table 18. Global Eye Drug Market Opportunities
Table 19. Global Eye Drug Market Challenges
Table 20. Key Manufacturers Eye Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Eye Drug Market Size, 2019 (MT) & (US$ Million)
Table 22. Eye Drug Factory Price by Manufacturers 2020 (USD/Kg)
Table 23. Location of Key Manufacturers Eye Drug Manufacturing Plants
Table 24. Key Manufacturers Eye Drug Market Served
Table 25. Date of Key Manufacturers Enter into Eye Drug Market
Table 26. Key Manufacturers Eye Drug Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Eye Drug Market Size by Type, 2020, (US$ Million)
Table 29. Global Eye Drug Market Size by Type, 2020 (MT)
Table 30. Global Eye Drug Price: by Type, 2020-2021 (USD/Kg)
Table 31. Global Eye Drug Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Eye Drug Market Size by Application, 2020-2021 (MT)
Table 33. Global Eye Drug Price: by Application, 2020-2021 (USD/Kg)
Table 34. Global Eye Drug Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Eye Drug Market Size by Region, 2019-2021 (MT)
Table 36. By Country, North America Eye Drug Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Eye Drug Market Size, 2019-2021 (MT)
Table 38. US Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 39. Canada Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Eye Drug Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Eye Drug Market Size, 2019-2021 (MT)
Table 43. Germany Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 44. France Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 45. UK Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 46. Italy Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Eye Drug Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Eye Drug Market Size, 2019-2021 (MT)
Table 50. China Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 51. Japan Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 52. South Korea Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 53. India Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 54. ASEAN Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 55. Latin America Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 56. Middle East and Africa Eye Drug Market Size, 2019-2021 (US$ Million) & (MT)
Table 57. Pfizer Business Overview
Table 58. Pfizer Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer Eye Drug Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Eye Drug Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. bausch Lomb Business Overview
Table 66. bausch Lomb Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. bausch Lomb Eye Drug Product
Table 68. bausch Lomb Response to COVID-19 and Related Developments
Table 69. Laboratoire Riva Business Overview
Table 70. Laboratoire Riva Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Laboratoire Riva Eye Drug Product
Table 72. Laboratoire Riva Response to COVID-19 and Related Developments
Table 73. Jamp Pharma Business Overview
Table 74. Jamp Pharma Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Jamp Pharma Eye Drug Product
Table 76. Jamp Pharma Response to COVID-19 and Related Developments
Table 77. Fresenius Business Overview
Table 78. Fresenius Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Fresenius Eye Drug Product
Table 80. Fresenius Response to COVID-19 and Related Developments
Table 81. Teva Pharmaceutical? Business Overview
Table 82. Teva Pharmaceutical? Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Teva Pharmaceutical? Eye Drug Product
Table 84. Teva Pharmaceutical? Response to COVID-19 and Related Developments
Table 85. SANDOZ Business Overview
Table 86. SANDOZ Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. SANDOZ Eye Drug Product
Table 88. SANDOZ Response to COVID-19 and Related Developments
Table 89. Greenstone Business Overview
Table 90. Greenstone Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Greenstone Eye Drug Product
Table 92. Greenstone Response to COVID-19 and Related Developments
Table 93. Mylan Business Overview
Table 94. Mylan Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Mylan Eye Drug Product
Table 96. Mylan Response to COVID-19 and Related Developments
Table 97. GE Medical Business Overview
Table 98. GE Medical Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. GE Medical Eye Drug Product
Table 100. GE Medical Response to COVID-19 and Related Developments
Table 101. Mint Pharmaceuticals Business Overview
Table 102. Mint Pharmaceuticals Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Mint Pharmaceuticals Eye Drug Product
Table 104. Mint Pharmaceuticals Response to COVID-19 and Related Developments
Table 105. Laboratoires Thea Business Overview
Table 106. Laboratoires Thea Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Laboratoires Thea Eye Drug Product
Table 108. Laboratoires Thea Response to COVID-19 and Related Developments
Table 109. Taj Pharmaceuticals Business Overview
Table 110. Taj Pharmaceuticals Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Taj Pharmaceuticals Eye Drug Product
Table 112. Taj Pharmaceuticals Response to COVID-19 and Related Developments
Table 113. Actavis Business Overview
Table 114. Actavis Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Actavis Eye Drug Product
Table 116. Actavis Response to COVID-19 and Related Developments
Table 117. APOTEX Business Overview
Table 118. APOTEX Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. APOTEX Eye Drug Product
Table 120. APOTEX Response to COVID-19 and Related Developments
Table 121. Sun Pharma Business Overview
Table 122. Sun Pharma Eye Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Sun Pharma Eye Drug Product
Table 124. Sun Pharma Response to COVID-19 and Related Developments
Table 125. Eye Drug Distributors List
Table 126. Eye Drug Customers List
Table 127. Covid-19 Impact on Eye Drug Customers
List of Figures
Figure 1. Eye Drug Product Picture
Figure 2. Eye Drug Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Eye Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Eye Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Eye Drug Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Eye Drug Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Eye Drug Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Eye Drug Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Eye Drug Market Size Market Share, 2019-2021

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3250
$ 4875

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top